Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-12-22

Clinical Trial Update: Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of adding a mood stabilizer to quetiapine (Seroquel) for maintenance treatment in Bipolar I Disorder has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mood Stabilizer
  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED